Insulin glargine, recombinant Subcutaneous and NovaLog Mix 50/50
Determining the interaction of Insulin glargine, recombinant Subcutaneous and NovaLog Mix 50/50 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: Insulin aspart and insulin aspart protamine, Insulin Aspart Protamine and Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Novamine
- Insulin glargine, recombinant Subcutaneous-Novamoxin
- Insulin glargine, recombinant Subcutaneous-Novamoxin Oral
- Insulin glargine, recombinant Subcutaneous-Novamoxin Reduced Sugar
- Insulin glargine, recombinant Subcutaneous-Novamoxin Reduced Sugar Oral, Injection, Intravenous, Intramuscular
- Insulin glargine, recombinant Subcutaneous-Novantrone
- NovaLog Mix 50/50-Insulin glulisine
- NovaLog Mix 50/50-Insulin Glulisine (Cartridges and Pens)
- NovaLog Mix 50/50-Insulin Glulisine (Vials)
- NovaLog Mix 50/50-Insulin glulisine Subcutaneous
- NovaLog Mix 50/50-Insulin human inhaled Inhalation
- NovaLog Mix 50/50-Insulin human regular Injection